Cost-Effectiveness of Carbidopa-Levodopa Enteral Suspension for Advanced Parkinson's Disease in the United States.

Rajesh Pahwa,Aristide Merola,Michael Soileau,Ali Alobaidi,A Simon Pickard,Prasanna L Kandukuri,Yanjun Bao,John Strezewski,Julia Oddsdottir,Weiwei Xu,David Standaert

Movement disorders : official journal of the Movement Disorder Society（2023）

引用 0|浏览6

暂无评分

摘要

CLES is a cost-effective treatment for aPD patients with medication resistant motor fluctuations. © 2023 AbbVie, Inc and The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要